CC BY 4.0 · Arq Neuropsiquiatr 2023; 81(12): 1053-1069
DOI: 10.1055/s-0043-1777115
View and Review

Cognitive impairment in post-acute COVID-19 syndrome: a scoping review

Comprometimento cognitivo na síndrome pós-COVID-19 aguda: uma revisão de escopo
1   Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Programa de Pós-graduação em Gerontologia, Campinas SP, Brazil.
,
1   Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Programa de Pós-graduação em Gerontologia, Campinas SP, Brazil.
,
2   Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brazil.
,
1   Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Programa de Pós-graduação em Gerontologia, Campinas SP, Brazil.
,
1   Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Programa de Pós-graduação em Gerontologia, Campinas SP, Brazil.
3   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-graduação em Gerontologia, São Paulo SP, Brazil.
,
1   Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Programa de Pós-graduação em Gerontologia, Campinas SP, Brazil.
3   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-graduação em Gerontologia, São Paulo SP, Brazil.
,
4   De Montfort University, Faculty of Health and Life Sciences, Leicester School of Nursing & Midwifery, United Kingdom.
,
1   Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Programa de Pós-graduação em Gerontologia, Campinas SP, Brazil.
3   Universidade de São Paulo, Escola de Artes, Ciências e Humanidades, Programa de Pós-graduação em Gerontologia, São Paulo SP, Brazil.
› Author Affiliations

Abstract

Emerging studies indicate the persistence of symptoms beyond the acute phase of COVID-19. Cognitive impairment has been observed in certain individuals for months following infection. Currently, there is limited knowledge about the specific cognitive domains that undergo alterations during the post-acute COVID-19 syndrome and the potential impact of disease severity on cognition. The aim of this review is to examine studies that have reported cognitive impairment in post-acute COVID-19, categorizing them into subacute and chronic phases. The methodology proposed by JBI was followed in this study. The included studies were published between December 2019 and December 2022. The search was conducted in PubMed, PubMed PMC, BVS – BIREME, Embase, SCOPUS, Cochrane, Web of Science, Proquest, PsycInfo, and EBSCOHost. Data extraction included specific details about the population, concepts, context, and key findings or recommendations relevant to the review objectives. A total of 7,540 records were identified and examined, and 47 articles were included. The cognitive domains most frequently reported as altered 4 to 12 weeks after acute COVID-19 were language, episodic memory, and executive function, and after 12 weeks, the domains most affected were attention, episodic memory, and executive function. The results of this scoping review highlight that adults with post-acute COVID-19 syndrome may have impairment in specific cognitive domains.

Resumo

Estudos emergentes indicam a persistência dos sintomas além da fase aguda da COVID-19. O comprometimento cognitivo foi observado em alguns indivíduos durante meses após a infecção. Atualmente, há pouco conhecimento sobre os domínios cognitivos específicos que sofrem alterações durante a síndrome pós-aguda da COVID-19 e o possível impacto da gravidade da doença na cognição. O objetivo desta revisão é examinar estudos que relataram comprometimento cognitivo na COVID-19 pós-aguda, categorizando-os em fases subaguda e crônica. A metodologia proposta pela Joanna Briggs Institute foi seguida neste estudo. Os estudos incluídos foram publicados entre dezembro de 2019 e dezembro de 2022. A busca foi realizada no PubMed, PubMed PMC, BVS – BIREME, Embase, SCOPUS, Cochrane, Web of Science, Proquest, PsycInfo e EBSCOHost. A extração de dados incluiu detalhes específicos sobre a população, os conceitos, o contexto e as principais descobertas ou recomendações relevantes para os objetivos da revisão. Um total de 7.540 registros foi identificado e examinado, e 47 artigos foram incluídos. Os domínios cognitivos mais frequentemente relatados como alterados de 4 a 12 semanas após a COVID-19 aguda foram linguagem, memória episódica e função executiva e, após 12 semanas, os domínios mais afetados foram atenção, memória episódica e função executiva. Os resultados dessa revisão de escopo destacam que adultos com síndrome pós-aguda da COVID-19 podem apresentar comprometimento em domínios cognitivos específicos.

Author's Contributions

GCC: study conception and design, interpretation, writing and review of the draft; VA: study conception and design, interpretation, and review of the draft; CLY: review of the draft; DA: review of the draft; MC: review of the draft; RCM: study design and draft review; KHS: draft interpretation and review; MSY: draft interpretation and review.


Supplementary Material



Publication History

Received: 18 August 2023

Accepted: 22 September 2023

Article published online:
29 December 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Crivelli L, Palmer K, Calandri I. et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimers Dement 2022; 18 (05) 1047-1066
  • 2 World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021
  • 3 Garg M, Maralakunte M, Garg S. et al. The Conundrum of ‘Long-COVID-19’: A Narrative Review. Int J Gen Med 2021; 14: 2491-2506
  • 4 Nalbandian A, Sehgal K, Gupta A. et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27 (04) 601-615
  • 5 Mao L, Jin H, Wang M. et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020; 77 (06) 683-690
  • 6 Lopez-Leon S, Wegman-Ostrosky T, Perelman C. et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Preprint. medRxiv 2021;
  • 7 Graham EL, Clark JR, Orban ZS. et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers”. Ann Clin Transl Neurol 2021; 8 (05) 1073-1085
  • 8 Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther 2020; 12 (01) 69
  • 9 Jakhmola S, Indari O, Chatterjee S, Jha HC. SARS-CoV-2, an Underestimated Pathogen of the Nervous System. SN Compr Clin Med 2020; 2 (11) 2137-2146
  • 10 Lu Y, Li X, Geng D. et al. Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study. EClinicalMedicine 2020; 25: 100484
  • 11 Douaud G, Lee S, Alfaro-Almagro F. et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 2022; 604 (7907): 697-707
  • 12 Chung HY, Wickel J, Brunkhorst FM, Geis C. Sepsis-Associated Encephalopathy: From Delirium to Dementia?. J Clin Med 2020; 9 (03) 703
  • 13 Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun 2020; 87: 34-39
  • 14 Tavares-Júnior JWL, de Souza ACC, Borges JWP. et al. COVID-19 associated cognitive impairment: A systematic review. Cortex 2022; 152: 77-97
  • 15 Peters MDJ, Marnie C, Tricco AC. et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Implement 2021; 19 (01) 3-10
  • 16 Tricco AC, Lillie E, Zarin W. et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med 2018; 169 (07) 467-473
  • 17 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372 (71) n71
  • 18 Crivelli L, Calandri I, Corvalán N. et al. Cognitive consequences of COVID-19: results of a cohort study from South America. Arq Neuropsiquiatr 2022; 80 (03) 240-247
  • 19 Cristillo V, Pilotto A, Piccinelli SC. et al. Predictors of “brain fog” 1 year after COVID-19 disease. Neurol Sci 2022; 43 (10) 5795-5797
  • 20 Kay CD, Costa AS, Vannorsdall TD. et al. Neuropsychological Outcomes of COVID-19: A Multicenter, Cross-Cultural Study of Patients Referred for Outpatient Assessment. COVID 2022; 2 (09) 1253-1264
  • 21 Priftis K, Velardo V, Vascello MGF. et al. Limited evidence for neuropsychological dysfunction in patients initially affected by severe COVID-19. Neurol Sci 2022; 43 (12) 6661-6663
  • 22 Delgado-Alonso C, Valles-Salgado M, Delgado-Álvarez A. et al. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J Psychiatr Res 2022; 150: 40-46
  • 23 Zhao S, Shibata K, Hellyer PJ. et al. Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Commun 2022; 4 (01) fcab295
  • 24 Albu S, Zozaya NR, Murillo N, García-Molina A, Chacón CAF, Kumru H. What's going on following acute covid-19? Clinical characteristics of patients in an out-patient rehabilitation program. NeuroRehabilitation 2021; 48 (04) 469-480
  • 25 Becker JH, Lin JJ, Doernberg M. et al. Assessment of Cognitive Function in Patients After COVID-19 Infection. JAMA Netw Open 2021; 4 (10) e2130645
  • 26 Hosp JA, Dressing A, Blazhenets G. et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 2021; 144 (04) 1263-1276
  • 27 Lamontagne SJ, Winters MF, Pizzagalli DA, Olmstead MC. Post-acute sequelae of COVID-19: Evidence of mood & cognitive impairment. Brain Behav Immun Health 2021; 17: 100347
  • 28 Liu YH, Wang YR, Wang QH. et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener 2021; 16 (01) 48
  • 29 Pistarini C, Fiabane E, Houdayer E, Vassallo C, Manera MR, Alemanno F. Cognitive and Emotional Disturbances Due to COVID-19: An Exploratory Study in the Rehabilitation Setting. Front Neurol 2021; 12: 643646
  • 30 Evans RA, McAuley H, Harrison EM. et al; PHOSP-COVID Collaborative Group. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021; 9 (11) 1275-1287
  • 31 Hampshire A. et al. “Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N= 84,285 online study.”. MedRxiv (2020): 2020-10
  • 32 Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health 2020; 9: 100163
  • 33 Woo MS, Malsy J, Pöttgen J. et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun 2020; 2 (02) fcaa205
  • 34 Miskowiak KW, Johnsen S, Sattler SM. et al. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol 2021; 46: 39-48
  • 35 Holdsworth DA, Chamley R, Barker-Davies R. et al. Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID. PLoS One 2022; 17 (06) e0267392
  • 36 Braga LW, Oliveira SB, Moreira AS. et al. Neuropsychological manifestations of long COVID in hospitalized and non-hospitalized Brazilian Patients. NeuroRehabilitation 2022; 50 (04) 391-400
  • 37 Carrillo-Garcia P, Garmendia-Prieto B, Cristofori G, Lozano-Montoya I, Gómez-Pavón J. Health impact on the elderly survivors of COVID-19: Six months follow up. Rev Esp Geriatr Gerontol 2022; 57 (03) 146-149
  • 38 Cecchetti G, Agosta F, Canu E. et al. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol 2022; 269 (07) 3400-3412
  • 39 Ferrucci R, Dini M, Rosci C. et al. One-year cognitive follow-up of COVID-19 hospitalized patients. Eur J Neurol 2022; 29 (07) 2006-2014
  • 40 Hadad R, Khoury J, Stanger C. et al. Cognitive dysfunction following COVID-19 infection. J Neurovirol 2022; 28 (03) 430-437
  • 41 Stavem K, Einvik G, Tholin B, Ghanima W, Hessen E, Lundqvist C. Cognitive function in non-hospitalized patients 8-13 months after acute COVID-19 infection: A cohort study in Norway. PLoS One 2022; 17 (08) e0273352
  • 42 Vannorsdall T, Oh ES. Post-acute cognitive and mental health outcomes amongst COVID-19 survivors: early findings and a call for further investigation. J Intern Med 2021; 290 (03) 752-754
  • 43 Del Brutto OH, Wu S, Mera RM, Costa AF, Recalde BY, Issa NP. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort. Eur J Neurol 2021; 28 (10) 3245-3253
  • 44 Bonizzato S, Ghiggia A, Ferraro F, Galante E. Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: preliminary data of an observational study. Neurol Sci 2022; 43 (01) 51-58
  • 45 Pilotto A, Cristillo V, Cotti Piccinelli S. et al. Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol Sci 2021; 42 (12) 4903-4907
  • 46 Alemanno F, Houdayer E, Parma A. et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PLoS One 2021; 16 (02) e0246590
  • 47 Carrillo-Garcia P, Garmendia-Prieto B, Cristofori G. et al. Health status in survivors older than 70 years after hospitalization with COVID-19: observational follow-up study at 3 months. Eur Geriatr Med 2021; 12 (05) 1091-1094
  • 48 Dressing A, Bormann T, Blazhenets G. et al. Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome. J Nucl Med 2022; 63 (07) 1058-1063
  • 49 Miskowiak KW, Fugledalen L, Jespersen AE. et al. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implications. Eur Neuropsychopharmacol 2022; 59: 82-92
  • 50 Weidman K, LaFond E, Hoffman KL. et al. Post-Intensive Care Unit Syndrome in a Cohort of COVID-19 Survivors in New York City. Ann Am Thorac Soc 2022; 19 (07) 1158-1168
  • 51 Blazhenets G, Schroeter N, Bormann T. et al. Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients. J Nucl Med 2021; 62 (07) 910-915
  • 52 Del Brutto OH, Rumbea DA, Recalde BY, Mera RM. Cognitive sequelae of long COVID may not be permanent: A prospective study. Eur J Neurol 2022; 29 (04) 1218-1221
  • 53 Frontera JA, Yang D, Medicherla C. et al. Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19: A Prospective Longitudinal Study. Neurology 2022; 99 (01) e33-e45
  • 54 Vialatte de Pémille C, Ray A, Michel A. et al. Prevalence and prospective evaluation of cognitive dysfunctions after SARS due to SARS-CoV-2 virus. The COgnitiVID study. Rev Neurol (Paris) 2022; 178 (08) 802-807
  • 55 Larsson IM, Hultström M, Lipcsey M, Frithiof R, Rubertsson S, Wallin E. Poor long-term recovery after critical COVID-19 during 12 months longitudinal follow-up. Intensive Crit Care Nurs 2023; 74: 103311
  • 56 Kim Y, Kim SW, Chang HH, Kwon KT, Bae S, Hwang S. Significance and Associated Factors of Long-Term Sequelae in Patients after Acute COVID-19 Infection in Korea. Infect Chemother 2021; 53 (03) 463-476
  • 57 Jaquet P, Legouy C, Le Fevre L. et al. Neurologic Outcomes of Survivors of COVID-19-Associated Acute Respiratory Distress Syndrome Requiring Intubation. Crit Care Med 2022; 50 (08) e674-e682
  • 58 Liu YH, Chen Y, Wang QH. et al. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol 2022; 79 (05) 509-517
  • 59 Mattioli F, Stampatori C, Righetti F, Sala E, Tomasi C, De Palma G. Neurological and cognitive sequelae of Covid-19: a four month follow-up. J Neurol 2021; 268 (12) 4422-4428
  • 60 Hartung TJ, Neumann C, Bahmer T. et al. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study. EClinicalMedicine 2022; 53: 101651
  • 61 Latronico N, Peli E, Calza S. et al; LOTO Investigators. Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS. Thorax 2022; 77 (03) 300-303
  • 62 Nersesjan V, Fonsmark L, Christensen RHB. et al. Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non-COVID-19 Illness. JAMA Psychiatry 2022; 79 (05) 486-497
  • 63 Ollila H, Pihlaja R, Koskinen S. et al. Long-term cognitive functioning is impaired in ICU-treated COVID-19 patients: a comprehensive controlled neuropsychological study. Crit Care 2022; 26 (01) 223
  • 64 Pfoh ER, Chan KS, Dinglas VD. et al; NIH NHLBI ARDS Network. Cognitive screening among acute respiratory failure survivors: a cross-sectional evaluation of the Mini-Mental State Examination. Crit Care 2015; 19 (01) 220
  • 65 Jaywant A, Vanderlind WM, Alexopoulos GS, Fridman CB, Perlis RH, Gunning FM. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology 2021; 46 (13) 2235-2240
  • 66 Seeßle J, Waterboer T, Hippchen T. et al. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin Infect Dis 2022; 74 (07) 1191-1198